| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |